HPV Vaccine at 20: Proven Cancer Prevention Tool Faces Uptake Challenges

The article marks the 20th anniversary of the FDA's approval of the first HPV vaccine in 2006, highlighting its evolution from a quadrivalent vaccine targeting cancer-causing HPV types 16/18 and wart-causing types 6/11 to newer formulations and schedules. It discusses the vaccine